Want to see IN:LOTUSEYE full AI Analyst Report?
Total Valuation
Lotus Eye Hospital And Institute Ltd has a market cap or net worth of ₹2.21B. The enterprise value is ₹2.23B.
Market Cap₹2.21B
Enterprise Value₹2.23B
Share Statistics
Lotus Eye Hospital And Institute Ltd has 20,796,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding20,796,330
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Lotus Eye Hospital And Institute Ltd’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.72%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)0.72%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee1.34M
Profits Per Employee2.00K
Employee Count402
Asset Turnover0.65
Inventory Turnover11.34
Valuation Ratios
The current PE Ratio of Lotus Eye Hospital And Institute Ltd is 1364.4. Lotus Eye Hospital And Institute Ltd’s PEG ratio is -27.83.
PE Ratio1364.4
PS Ratio3.68
PB Ratio3.28
Price to FCF-18.58
Price to Operating Cash Flow446.04
PEG Ratio-27.83
Income Statement
In the last 12 months, Lotus Eye Hospital And Institute Ltd had revenue of 537.14M and earned 804.00K in profits. Earnings per share was 0.04.
Revenue537.14M
Gross Profit102.25M
Operating Income-3.67M
Pretax Income-536.00K
Net Income804.00K
EBITDA45.55M
Earnings Per Share (EPS)0.04
Cash Flow
In the last 12 months, operating cash flow was 5.09M and capital expenditures -7.77M, giving a free cash flow of -2.68M billion.
Operating Cash Flow5.09M
Free Cash Flow-2.68M
Free Cash Flow per Share-0.13
Dividends & Yields
Lotus Eye Hospital And Institute Ltd pays an annual dividend of ₹0.5, resulting in a dividend yield of 0.59%
Dividend Per Share₹0.5
Dividend Yield0.59%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.75
52-Week Price Change-18.01%
50-Day Moving Average112.24
200-Day Moving Average115.25
Relative Strength Index (RSI)38.80
Average Volume (3m)2.85K
Important Dates
Lotus Eye Hospital And Institute Ltd upcoming earnings date is Nov 17, 2026, TBA (Confirmed).
Last Earnings DateAug 10, 2026
Next Earnings DateNov 17, 2026
Ex-Dividend Date―
Financial Position
Lotus Eye Hospital And Institute Ltd as a current ratio of 1.22, with Debt / Equity ratio of 0.00%
Current Ratio1.22
Quick Ratio0.81
Debt to Market Cap0.06
Net Debt to EBITDA3.08
Interest Coverage Ratio-0.43
Taxes
In the past 12 months, Lotus Eye Hospital And Institute Ltd has paid -1.34M in taxes.
Income Tax-1.34M
Effective Tax Rate2.50
Enterprise Valuation
Lotus Eye Hospital And Institute Ltd EV to EBITDA ratio is 46.42, with an EV/FCF ratio of -19.89.
EV to Sales3.94
EV to EBITDA46.42
EV to Free Cash Flow-19.89
EV to Operating Cash Flow87.54
Balance Sheet
Lotus Eye Hospital And Institute Ltd has ₹38.27M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹38.27M billion.
Cash & Marketable Securities₹38.27M
Total Debt₹0.00
Net Cash₹38.27M
Net Cash Per Share₹1.84
Tangible Book Value Per Share₹29.81
Margins
Gross margin is 25.47%, with operating margin of -0.68%, and net profit margin of 0.15%.
Gross Margin25.47%
Operating Margin-0.68%
Pretax Margin-0.10%
Net Profit Margin0.15%
EBITDA Margin8.48%
EBIT Margin1.50%
Analyst Forecast
The average price target for Lotus Eye Hospital And Institute Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast14.08%
EPS Growth Forecast-77.40%